Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has provided an announcement.
Charmacy Pharmaceutical Co., Ltd. announced the successful passing of all resolutions during its Annual General Meeting held on May 22, 2025. Key resolutions included the approval of the 2024 financial statements, amendments to meeting procedures, and the distribution of the 2024 final dividend. The company also approved a comprehensive revolving credit line of up to RMB 2.8 billion, which is expected to enhance its financial flexibility and support future operations.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, primarily engaged in the production and distribution of pharmaceutical products. The company focuses on providing a wide range of pharmaceutical solutions to meet market demands.
Average Trading Volume: 2,842
Technical Sentiment Signal: Sell
Current Market Cap: HK$831.6M
For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.